Welcome to ExcellGene.

We are a science and technology driven CRO/CMO for recombinant protein or virus-like particle (VLP) production, cell line generation, process development and cGMP master cell banking.

FEATURED PAPER

CHO Quasispecies – Implication for Manufacturing Processes

#1 Most Cited Article – Processes

Written by ExcellGene founder and CSO Florian M. Wurm, the paper now exceeds 8000 downloads, and stands as the #1 most cited paper in Processes journal. It summarises decades of studies of CHO cell genetics and how certain approaches can avoid stability issues for manufacturing processes.


Link to paper, free pdf download
CHO Quasispecies – Implication for Manufacturing Processes
Wurm, Florian M. (2013)

WHAT WE DO

Everything from DNA vector to purified product and process for large-scale manufacturing.

We cover the value chain from DNA construction & transfection, to scalable process development, to rapid protein manufacture or VLP production and the development of scalable (GMP) processes.

ExcellGene™ technologies are the most advanced for rapid production of recombinant proteins or virus vectors – transient or stable.

Cell-line Development

From DNA to high-yielding clonal population.

Rapid Protein Production

Production in weeks from 1mL to 100L scale.

Process Development for High Yield

Fine-tuning of media and process conditions, parameters for virus or protein.

VLP Production

HEK cell-based production 1ml to 10L,
baculo virus-free.

cGMP Master Cell Banking

Compliant with GMP standards.

Cell-line Development

From DNA to high-yielding clonal population.

Rapid Protein Production

Production in weeks from 1mL to 100L scale.

Process Development for High Yield

Fine-tuning of media and process conditions, parameters for virus or protein.

VLP Production

HEK cell-based production 1ml to 10L; no baculo virus use.

~

cGMP Master Cell Banking

Compliant with GMP standards.

TECHNOLOGIES

Pioneering, on every level.

The company has developed proprietary technologies and know-how that are key for the delivery of its clients’ projects on a timely manner and with a high degree of customization.

Some are also available to license.

CHO Transient Transfection Kit

Inhouse protein expression, made easy.

CHOexpress™ host cells

The fastest growing CHO host for biotech.

HEKExpress™ host cells

Pioneering single-cell suspension for transient gene expression.

OrbShake bioreactors

Original technology generated by ExcellGene scientists.

Clients from all around the world.

ExcellGene has assisted more than a hundred clients since inception, which include 6 of the top 10 pharma companies, biotech companies, contract research organizations and academic institutions.

%

Biotech

%

Big pharma

%

Academic

%

Other

  • Biotech 47%
  • Big pharma 25%
  • Academic 10%
  • Other 18%

Ready to kickstart your projects?

Welcome to ExcellGene.

We are a science and technology driven CRO/CMO for recombinant protein or virus-like particle (VLP) production, cell line generation, process development and cGMP master cell banking.

FEATURED PAPER

CHO Quasispecies – Implication for Manufacturing Processes

#1 Most Cited Article – Processes

Written by ExcellGene founder and CSO Florian M. Wurm, the paper now exceeds 8000 downloads, and stands as the #1 most cited paper in Processes journal. It summarises decades of studies of CHO cell genetics and how certain approaches can avoid stability issues for manufacturing processes.


Link to paper, free pdf download
CHO Quasispecies – Implication for Manufacturing Processes
Wurm, Florian M. (2013)

©ExcellGene S.A., Route de l’Ile-au-Bois 1A, 1870 Monthey, Switzerland.